Literature DB >> 12225808

Highly sulfated glycosaminoglycans inhibit aggrecanase degradation of aggrecan by bovine articular cartilage explant cultures.

Shannon E Munteanu1, Mirna Z Ilic, Christopher J Handley.   

Abstract

The catabolism of 35S-labeled aggrecan and loss of tissue glycosaminoglycans was investigated using bovine articular cartilage explant cultures maintained in medium containing 10(-6) M retinoic acid or 40 ng/ml recombinant human interleukin-1alpha (rHuIL-1alpha) and varying concentrations (1-1000 microg/ml) of sulfated glycosaminoglycans (heparin, heparan sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate, dermatan sulfate and keratan sulfate) and calcium pentosan polysulfate (10 microg/ml). In addition, the effect of the sulfated glycosaminoglycans and calcium pentosan polysulfate on the degradation of aggrecan by soluble aggrecanase activity present in conditioned medium was investigated. The degradation of 35S-labeled aggrecan and reduction in tissue levels of aggrecan by articular cartilage explant cultures stimulated with retinoic acid or rHuIL-1alpha was inhibited by heparin and heparan sulfate in a dose-dependent manner and by calcium pentosan polysulfate. In contrast, chondroitin 4-sulfate, chondroitin 6-sulfate, dermatan sulfate and keratan sulfate did not inhibit the degradation of 35S-labeled aggrecan nor suppress the reduction in tissue levels of aggrecan by explant cultures of articular cartilage. Heparin, heparan sulfate and calcium pentosan polysulfate did not adversely affect chondrocyte metabolism as measured by lactate production, incorporation of [35S]-sulfate or [3H]-serine into macromolecules by articular cartilage explant cultures. Furthermore, heparin, heparan sulfate and calcium pentosan polysulfate inhibited the proteolytic degradation of aggrecan by soluble aggrecanase activity. These results suggest that highly sulfated glycosaminoglycans have the potential to influence aggrecan catabolism in articular cartilage and this effect occurs in part through direct inhibition of aggrecanase activity. Copyright 2002 Elsevier Science B.V. and International Society of Matrix Biology

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12225808     DOI: 10.1016/s0945-053x(02)00034-3

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  8 in total

1.  In vitro ovine articular chondrocyte proliferation: experiments and modelling.

Authors:  L Mancuso; M I Liuzzo; S Fadda; M Pisu; A Cincotti; M Arras; G La Nasa; A Concas; G Cao
Journal:  Cell Prolif       Date:  2010-04-14       Impact factor: 6.831

2.  Experimental analysis and modelling of in vitro HUVECs proliferation in the presence of various types of drugs.

Authors:  L Mancuso; M Scanu; M Pisu; A Concas; G Cao
Journal:  Cell Prolif       Date:  2010-12       Impact factor: 6.831

3.  Experimental analysis and modelling of in vitro proliferation of mesenchymal stem cells.

Authors:  L Mancuso; M I Liuzzo; S Fadda; M Pisu; A Cincotti; M Arras; E Desogus; F Piras; G Piga; G La Nasa; A Concas; G Cao
Journal:  Cell Prolif       Date:  2009-07-10       Impact factor: 6.831

4.  Dermatan sulphate in methoxy polyethylene glycol-polylactide-co-glycolic acid scaffolds upregulates fibronectin gene expression but has no effect on in vivo osteochondral repair.

Authors:  Casper Bindzus Foldager; Cody Bünger; Anna Bay Nielsen; Michael Ulrich-Vinther; Samir Munir; Hanne Everland; Martin Lind
Journal:  Int Orthop       Date:  2012-01-20       Impact factor: 3.075

5.  Determinants of versican-V1 proteoglycan processing by the metalloproteinase ADAMTS5.

Authors:  Simon J Foulcer; Courtney M Nelson; Maritza V Quintero; Balagurunathan Kuberan; Jonathan Larkin; Maria T Dours-Zimmermann; Dieter R Zimmermann; Suneel S Apte
Journal:  J Biol Chem       Date:  2014-08-13       Impact factor: 5.157

6.  High resistance of the mechanical properties of the chondrocyte pericellular matrix to proteoglycan digestion by chondroitinase, aggrecanase, or hyaluronidase.

Authors:  Rebecca E Wilusz; Farshid Guilak
Journal:  J Mech Behav Biomed Mater       Date:  2013-10-03

Review 7.  Aggrecanases and cartilage matrix degradation.

Authors:  Hideaki Nagase; Masahide Kashiwagi
Journal:  Arthritis Res Ther       Date:  2003-02-14       Impact factor: 5.156

8.  Systems Based Study of the Therapeutic Potential of Small Charged Molecules for the Inhibition of IL-1 Mediated Cartilage Degradation.

Authors:  Saptarshi Kar; David W Smith; Bruce S Gardiner; Alan J Grodzinsky
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.